Status:
COMPLETED
Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Glioma
Brain Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective is to evaluate and quantify the reproducibility of functional magnetic resonance imaging (fMRI) maps of the eloquent brain areas corresponding to specific neurological functions ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Indication for brain radiotherapy.
- Ability to undergo MRI scans and time to participate in neurocognitive testing.
Exclusion
Key Trial Info
Start Date :
June 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT00214175
Start Date
June 1 2004
End Date
January 1 2011
Last Update
February 24 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States, 53792